SEI Investments’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$314K Buy
12,066
+3,262
+37% +$98.5K ﹤0.01% 2843
2026
Q2
$288K Sell
8,804
-1,190
-12% -$38.2K ﹤0.01% 2887
2026
Q1
$325K Sell
9,994
-6,637
-40% -$218K ﹤0.01% 2799
2025
Q4
$528K Buy
16,631
+181
+1% +$5.44K ﹤0.01% 2487
2025
Q3
$387K Buy
+16,450
New +$282K ﹤0.01% 2351

Other funds holding STOK

SEI Investments's STOK Position: Q3 2026 in Review

SEI Investments increased its Stoke Therapeutics (STOK) stake by 37% in Q3 2026, buying an estimated $98.5K and bringing the position to 12,066 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

SEI Investments first reported a position in STOK in Q3 2025 and has held it in 5 quarters since. The position peaked at $528K in Q4 2025. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • SEI Investments held 12,066 shares of Stoke Therapeutics worth $314K as of Q3 2026.
  • SEI Investments bought 3,262 Stoke Therapeutics shares in Q3 2026, an estimated $98.5K.
  • Stoke Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2843 holding.
  • SEI Investments first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • SEI Investments's Stoke Therapeutics position peaked at $528K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.